Toxicological evaluation and antitumoral effect of hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma treatment.
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2017
At a glance
- Drugs Ethiodized oil (Primary) ; Fluorouracil (Primary) ; Nimotuzumab (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 01 Sep 2011 New trial record